20 September 2016 EMA/428004/2016 Stakeholders and Communication Division

Agenda - EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting 20 September 2016, 08:30hrs to 16:30hrs – meeting room: 2A

Chair: Isabelle Moulon (EMA) 20 September 2016 08:30

Action

Speaker

Registration and reimbursement arrangements (HCPWP)

1. Election of HCPWP co-chair (HCPWP members only) 08:45

Welcome and introduction / Health and safety information

I. Moulon (EMA)

Disclosure of interests / Adoption of the agenda 08:50

1.1 HCPWP co-chair election proceedings

Election

I. Silva / A. Spina (EMA)

1.2 Nomination of observers to the PCWP 09:30

1.3 EMA revised framework of interaction with

For agreement

I. Silva (EMA)

healthcare professionals After the election is finalised HCPWP members leave the room to return at 11h15 10:00

Registration and reimbursement arrangements (PCWP)

2. Election of PCWP co-chair (PCWP members only) 10:15

Welcome and introduction / Health and safety information

I. Moulon (EMA)

Disclosure of interests / Adoption of the agenda 10:20

2.1 PCWP co-chair election proceedings 2.2 Nomination of observers to the HCPWP

11:00

Election

N. Bere / A. Spina (EMA)

Coffee Break

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

20 September 2016

Action

Speaker

For

M. Papaluca (EMA)

3. Personalised medicine 11:15

3.1 Recent developments

information 11:35

3.2 Forward together: EAPM achievements and initiative (2016-17)

12:00

3.3 What are the areas of interest and concern

For

D. Horgan (EAPM)

information For discussion

Open discussion

For

PCWP/HCPWP

information/

Committee members

for patients and healthcare professionals 12:45

Lunch

4. Committee feedback 13:30

4.1 Feedback from scientific committees

discussion 5. Members voice: sharing practices 14:00

5.1 Health Literacy, Young Patients with Asthma and Adherence to Treatment

14:20

5.2 State of Health in the EU: the Community Pharmacy Contribution

14:30

For

E. Botjes (EFA)

information For

J. Wilkinson (PGEU)

information

Coffee break

6. Working party organisational matters 14:45

6.1 Progress report from PCWP and HCPWP topics groups

For

PCWP/HCPWP co-

information/

leads

discussion 15:15

6.2 PCWP and HCPWP work programmes for

For agreement

2017 15:45

6.3 EMA framework of collaboration with academia

7. AOB 16:30

End of meeting

N. Bere/ I. Silva (EMA)

For information

M. Ensini (EMA)

Agenda - European Medicines Agency - Europa EU

Sep 20, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... 20 September 2016, 08:30hrs to 16:30hrs – meeting room: 2A.

187KB Sizes 1 Downloads 208 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Nov 3, 2016 - Scope: 'Optimising the development of ATMPs to meet patient needs' ... the CAT would like to discuss with company representatives in person.

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - under Article 107i of Directive 2001/83/EC, based on pharmacovigilance data. Action: For adoption of ..... manufacturing process; and 3) removal of the following missing information: special patient groups. Action: For .... analysis of

Agenda - European Medicines Agency - Europa EU
4 days ago - Meningococcal group A, C, W135 and Y conjugate vaccine - NIMENRIX (CAP) -. EMEA/H/C/002226/II/0078 . ...... Applicant: AstraZeneca AB.

Agenda - European Medicines Agency - Europa EU
Jul 31, 2017 - Human Medicines Research and Development Support Division. Agenda ... use of such prior knowledge in regulatory application dossiers, to support manufacturing and control strategies ... of accelerated access schemes.

Agenda - European Medicines Agency - Europa EU
Oct 26, 2016 - (as Web sites for social networking and microblogging) through which ... 09:10. Opening remarks. D. Haerry (PCWP)/. G. Calvo (HCPWP). 1.

Agenda - European Medicines Agency - Europa EU
Nov 27, 2017 - Some of the information contained in this agenda is considered commercially confidential or sensitive and therefore not disclosed. With regard to intended therapeutic indications or procedure scopes listed against products, it must be